Últimas noticias sobre Biora Therapeutics (OTC:BIOR) Bolsa

Biora Therapeutics

Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.

Biora Therapeutics Inc

BIORA THERAPEUTCS INC by Biora Therapeutics, Inc.

BioRegenx Inc

BioRestorative Therapies, Inc. - Common Stock

BioRestorative Therapies Inc

Biorem Inc

Markets

Press Releases

Biora Therapeutics Announces Positive Nasdaq Listing Decision

Biora Therapeutics Achieves ISO 13485 Certification

News

Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024

Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium

Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting

Health Care

Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting

Financing

Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update

Earnings

Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth

BIOR

HC Wainwright & Co.

Comments

Biora Therapeutics

Noticias

Últimas noticias sobre Biora Therapeutics (OTC:BIOR) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL